冠狀動(dòng)脈粥樣硬化性心臟病英文課件_第1頁(yè)
冠狀動(dòng)脈粥樣硬化性心臟病英文課件_第2頁(yè)
冠狀動(dòng)脈粥樣硬化性心臟病英文課件_第3頁(yè)
冠狀動(dòng)脈粥樣硬化性心臟病英文課件_第4頁(yè)
冠狀動(dòng)脈粥樣硬化性心臟病英文課件_第5頁(yè)
已閱讀5頁(yè),還剩85頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

CoronaryAtheroscleroticHeartDiseasesAffiliatedHospitalofJiningMedicalCollegeDept.ofCardiacCareUnitGuoxiaDongdong.0321@163.com25/14/2024ContentsAtherosclerosisStableAnginaPectorisAcuteCoronarySyndromeUAandNSTEMIAMI(STEMI)35/14/2024Self-study

VariantAnginaCardiacSyndromeXSilentMyocardialIschemiaMyocardialBridging45/14/2024WhatIsAtherosclerosis?Atherosclerosisisthedescriptivetermforthickenedandhardenedlesionsofthemediumandlargemuscularandelasticarteries.55/14/2024WhatIsCoronaryHeartDisease?65/14/2024CoronaryheartdiseaseatherosclerosisCoronarystenosiscoronaryspasmMyocardialischemia,necrosisIschemicheartdisease75/14/202485/14/2024Atherosclerosis95/14/2024FoamcellFattysteak

atheromatousplaquerupturedplaquesFibrousplaqueEndothelialdamagefirstdecadeThirddecadeForthdecadeAdaptedfromStaryHCetal.Circulation1995;92:1355-1374.mediumdamage5/14/202410Whatdamagedoesatherosclerosiscause?

115/14/2024CommonlocationCoronaryHeartDiseaseCarotidArteryDiseasePeripheralArterialDiseaseChronicKidneyDisease125/14/2024Howdoesatherosclerosisstartandprogress?135/14/2024ElevatedlevelsofcholesterolandtriglyceridesinthebloodHighbloodpressureCigarettesmoking145/14/2024BiologicalprocessesAccumulationofintimalcellssmoothmusclecellsMacrophagesT-lymphocytes155/14/2024BiologicalprocessesProliferatedconnectivetissuematrixcollagenelastic

fibersproteoglycans

165/14/2024Biologicalprocesses3.Accumulationoflipid175/14/2024Atherosclerosis-Hypothesis

HypothesisoflipoproteininfiltrationAggregationofplateletsandthrombosisClonaltheoryTheresponse-to-injuryhypothesis185/14/2024Highbloodpressure,bacterium,virus,toxin,ox-LDL,immunefactor,vasoactivesubstance.Plateletsareactivated,

adhesionandaggregationofplatelets.Lipidoses,growthfactor,proliferationofsmoothmuclecells,collagen,lipolyticenzyme.Response-to-injury

195/14/2024Pathologyandpathophysiology

FattysteakFibrousplaqueComplicatedlesion205/14/2024InitiationofAtherosclerosis

Fattysteakformation215/14/2024InitiationofAtherosclerosis225/14/2024fibrousplaque235/14/2024245/14/2024

255/14/2024ThinCapVulnerablePlaqueThrombusUnstable“ActiveVolcano”ThickCapCalcifiedPlaqueFlow-limitingLesionStableAngina“DormantVolcano”SAPACSpressureorasqueezingpain!!!265/14/2024UnstableandStablePlaques薄的纖維帽炎性細(xì)胞少的平滑肌細(xì)胞內(nèi)皮細(xì)胞不完整巨噬細(xì)胞較厚的纖維帽沒(méi)有炎性細(xì)胞泡沫細(xì)胞完整的內(nèi)皮細(xì)胞較多平滑肌細(xì)胞LibbyP.Circulation.1995;91:2844-2850.unstablestable5/14/202428Atherosclerosis

ClinicalstagesAbsenceofsymptomorstageofincubationischemianecrosis(target

organ)fibrosis295/14/2024clinicalmanifestation

GeneralmanifestationAorticatherosclerosisCoronaryarteryatherosclerosisCerebral

atherosclerosisRAatherosclerosisMesentericatherosclerosisPeripheral

arteryatherosclerosis305/14/2024Laboratory

ExaminationLackofsensitiveandspecificmethodsforearlydiagnosisDyslipidemiaX-ray:DSAshowseverityofstenosisDopplerultrasound:bloodflow315/14/2024Laboratory

Examinationradionuclide:detectionofischemiaEchocardiogram:CHDECGandstresstest:CHDAngiography:themostdirectwayIntravascularultrasound,angioscopeCT,MRI325/14/2024Riskfactors

1.Lipiddisorders(Dyslipidemia)Increasedcholesterol:TcandLDL-c,TG,ApoB,Lp(a)Decreasedcholesterol:HDL-capoA2.Hypertension335/14/2024Riskfactors3.DM,MetabolicsyndromeorinsulinresistancesyndromeMorediffuselesionCADequivalent75-80%causeofdeathinadultDMarevasculardiseases:CAD,cerebrovasculardisease,orperipheralvasculardisease345/14/20247yearsincidenceofdeath/non-fatalMI(EastWestStudy)*ThesepatientshadnohistoryofmyocardialinfarctionHaffnerSM,etal.NEnglJMed.1998;339:229–234.05101520253035404550EventsofMIin7yearsNohistoryofMIOMINohistoryofMI*OMInon-diabetics diabetics n=1373 n=1059P<0.001P<0.0014%19%20%45%DM:CADequivalent355/14/2024Riskfactors

4.

Cigarettesmoking:morethrombogenic5.

Familyhistory6.

Aging:>40yrsadults,4/5fatalmyocardialinfarctionoccuredinpatiens>65yrs7.Malegender/postmenopausalstate:male:female=2:1,mendevelopCHD10-15yrsearlierthanwomen8.alcohol9.Others:diet,homocysteine,hemostaticfactorsinflammation/infection365/14/2024

Drugtherapy

anti-platelet:

aspirin,clopidogrel,GPIIb/IIIainhitibor,Dipyridamole,cilostazolLipid-loweringHMG-CoAreductaseinhibitors(statins)375/14/2024DoubtsofpatientsQuest1:Mybloodpressureisonlyabout100/60mmHg,Whygivemehypotensorlotensin?385/14/2024DoubtsofpatientsQuestion2:Myshapeisnotfat,lipidisnothigh,whygivemelipid-loweringdrugs,madeamistake?395/14/2024DoubtsofpatientsQuestion3:Ihavecoronaryheartdisease,thenshouldIdolessactivities

inordertoprotecttheheart?405/14/2024

CoronaryHeartDisease(CHD)

5/14/202441ClinicalTypeSilentmyocardialischemiaAnginapectorisMyocardialinfarctionIschemiccardiomyopathySuddencardiacdeath5/14/202442SilentMyocardialIschemiaDefinedasdocumentedepisodesofischemianotassociatedwithanytypicaloratypicalsymptomsthatamongpatientswithobstructivecoronaryarterydisease.TypeI:myocardialischemiaisdetectedonroutineECG,24hambulatoryECGmonitoring(Holter),etc.butnotexperienceanginaatanytime;TypeII:patientsaremostfrequentlyencounteredinclinicalpractice.Someepisodesofischemiaareassociatedwithchestdiscomfortandotherepisodesareasymptomatic.5/14/202443IschemicCardiomyopathySymptomsofheartfailure,causedbyischemicmyocardialdysfunction,diffusefibrosis,andmultipleinfarction,aloneorincombination.Manifestations:ventriclesenlargement(dominantleftventricle),heartfailureandarrhythmias.5/14/202444SuddenCardiacDeathSCDisnaturaldeathduetocardiaccauses,heraldedbyabruptlossofconsciousnesswithin1houroftheonsetofacutesymptoms.Thetimeandmodeofdeathareunexpected.WHOdefinition:unexpecteddeathwithin6hours.Thisdefinitionincorporatesthekeyelementsofnatural,

rapidandunexpected.OnehalfofSCDduetocoronaryheartdisease,causedbyseverearrhythmias,suchasventricularfibrillationandcardiacarrest.5/14/202445AcuteCoronarySyndromeACSrepresentsaspectrumofconditions.Acuteplaquechangecharacterizedbyplaqueruptureandexposureofsubstancesthatpromoteplateletactivationandthrombingeneration.5/14/202446STABLEANGINAPECTORIS475/14/2024Definition

Acuteandtransientmyocardialischemiaandanoxaemia.Usuallycausedbycoronaryinsufficiencyduringexertion.485/14/2024Characteristicsparoxysmalprecordialsqueezing-likechestpain,behindthemidsternumradiatedtoleftshoulderandupperarmprecipitatedbystressorexertionrelievedrapidlybyrestornitrates495/14/2024

hypoxiaCoronarystenosis(others:aorticvalvedisease,HOCM)+Myocardialoxygendemand(HRXSBP)increased

myocardialhypoxiaacumulationofmetabolicproduct,stimulateC1-5tocausethesensationofchestpain

mechanism505/14/2024inangiographySignificantcoronarylesionwithdiameterstenosis>70%in75%ptsNosignificantstenosisinabout5-10%pts,Ischemiamayberelatedtocoronaryspasmormicrovasculardysfunction.PathologyStableanginapectoris515/14/2024pathophysiology1.MetabolicandelectrophysiologyATPreduced,accumulationofacidsubstancesDysfunctionofionpump(Na+-K+,andNa+-Ca++)Earlydepolarization(STdeviation)2.LVfunctionandhemodynamicsituationLVcontractility,systolicBP,strokevolume,cardiacoutputdecreasedLVEDpressureandvolumeStunningofmyocardiumStableanginapectoris525/14/2024symptom:chestpainlocation

behindorslightlytotheleftofthemidsternumnodefiniteborderlineradiatedtotheleftshoulderandupperarmAtypicallocation:lowerjaw,thebackofneckClinicalmanifestationStableanginapectoris535/14/2024character:tightness,squeezing,burning,pressing,choking,bursting,rarelysharpduration:3-5minsprecipitatingfactor

exertionoremotionalagitationpainrelief:withinseveralminsafterrestorusingnitroglycerinClinicalmanifestationStableanginapectoris555/14/2024PhysicalexaminationincreasedHR,elevatedBPanxietycoolandsweatyskinoccasionally

galloprhythm,transientsystolicmurmurClinicalmanifestationStableanginapectoris565/14/2024

Auxiliaryexamination1.ECG:Resting

ECGECGduringchestpain:ST-Tchangefoundin95%ptsHolter:detectofslientischemiaStresstesting:Criteriaforpositive:STsegmentdepression

0.1mV,last2minscontraindication:AMI,UAP,myocarditis,Hypertension,heartfailure,aorticstenosis,HOCM,severarrhythmia,aorticaneurysmEndofthetest:STor≥0.2mV,APattacks,BP>220mmHg,BPdrop,ventriculararrhythmiaStableanginapectoris575/14/2024StresstestrestExersciseStableanginapectoris585/14/2024

2.Echocardiography:3.Scintigraphyassessment:CandetectfillingdefectofInfarctionarea4.X-rayofheart 5.coronaryangiography:finaldiagnose6.others:IVUSAuxiliaryexaminationStableanginapectoris595/14/2024CoronaryAngiography605/14/2024StableAnginaPectorisDiagnosisChestpainriskfactorsECGevidenceofischemiaduringchestpainangiography615/14/2024Cardiovascular

causesNoncardiaccausesStableAnginaPectorisDifferentialdiagnosis625/14/2024Cardiovascular

cause

MyocardialinfarctionPericarditisAorticdissectionPulmonaryembolismPulmonaryhypertension635/14/2024Noncardiac

cause

PneumoniawithpleurisySpontaneouspneumothoraxMusculoskeletaldisordersHerpeszosterEsophagealrefluxPepticulcer645/14/2024Generaltreatment:riskfactorscontrol2.Drugtherapy3.Coronaryrevascularization:percutaneouscoronaryintervention(PCI)Coronaryarterybypasssurgery(CABG)SVG,IMAGTreatmentStableAnginaPectoris655/14/2024BloodandoxygensupplytotheheartMyocardial

bloodflowMyocardialoxygen

consumption4%oftotal

cardiacoutput

suppliedtothe

myocardium12%oftotalbodyoxygen,

usedatrestby

myocardium5/14/202466CoronaryReserveMyocardial

bloodflow

increasesupto

4times...…tomeet

increased

myocardialoxygen

demand5/14/202467Myocardialoxygen

supplyanddemandO2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2O2supplyO2demand5/14/202468AimsofmedicaltherapyArterialvasodilatationReducesarterial

resistanceReducesafterloadDecreases

sympatheticdriveReduceheartrate

andcontractileforceReducescardiacworkLVRVDilatationof

coronaryarteriesImprovescoronary

supplyVenodilatationReduces

venousreturnReducespreload5/14/202469antianginalandanti-ischemictherapyDrugtherapyOxygensupplyOxygendemanda.Nitratesb.Betablockersc.Calciumantagonistsd.DrugsimprovingmetabolismStableAnginaPectoris705/14/2024Drugtherapya.Nitratesloweroxygendemand:decreasearteriolarandvenoustone,reducepreloadandafterloadincreasecoronarysupply:CoronarydilatationNitroglycerinIsosorbidedinitrateisosorbide5-mononitrate(long-actingnitrates)StableAnginaPectoris715/14/2024NitratesinanginaReducepreload

through

venodilatationReduceafterloadby

loweringarterialresistanceReduceplateletaggregationIncreasecoronaryperfusion,includingischaemicareasReversalofcoronaryspasm5/14/202472b.?-blockers:reducemyocardialoxygen:reduceHR,myocardialcontractility,BP,theLVwallstressAbslutecontraindications:severbradycardia:high-degreeA-Vblock,SSS,severeunstableLVfailureRelativecontraindications:asthmaandbronchospasticdiseaseperipheralvasculardisease?1-selective:metoprolol,atenolol,bisoprololDrugtherapyStableAnginaPectoris735/14/2024c.Calciumantagonists:Increaseoxygensupply:dilateconduitandresistancevessels,releasespasm,improvemicrovascularfunctionDecreaseoxygendemand:negativeinotropiceffect,decreaseBPAntiplateleteffectd.DrugsimprovingmetabolismDrugtherapyStableAnginaPectoris745/14/2024preventMIanddeaththerapya.antiplateletangents:ASAclopidogrelCilostazolb.Lipid-loweringangents:statinsc.Angiotesin-convertingenzymeinhibitor(ACEI)DrugtherapyStableAnginaPectoris755/14/2024stentingStableAnginaPectoris765/14/2024UnstableAngina(UA)andnon-STEMI775/14/2024ACSNon-STelevationSTelevationUnstableanginaNon-QwaveAMIQwaveAMI*positiveserumcardiacmarkers****##occasionallyvariantanginaAcuteCoronarySyndrome(ACS)785/14/2024PathophysiologyofACS

stableangina UAP&non-Q-wAMI Q-wAMIAngiographicthrombus

0-1% 75% >90%IncreasedFPA/TAT 0-5% 60-80% 80-90%Activatedplatelets 0-5% 70-80% 80-90%Acutecoronaryocclusion 0-1% 10-25% >90%mortality 1-2% 3-8% 6-15%FPA:fibrinopeptideATAT:thrombin-antithrombincomplexesUAandnon-STEMI795/14/2024Occuringatrest(orwithmininalexertion):last>20minsseverandofnew-onset:within1-2months,CCSIIIOccuringwithacrescendopattern:DeteriorationofCCSclassfication,atleastCCSIIIDefinition

UAandnon-STEMIAnginapectorisorequivalentischemicdiscomfortwithatleastoneofthethreefeatures805/14/2024BraunwaldclassificationofunstableanginaSeverity:ClassI:New-onset,oracceleratedsevereanginanorestpainwithin2monthsClassII:Anginaatrest,subacuteanginaatrest(withintheprecedingmonthbutnotwithin48h)ClassIII:Anginaatrest,acute(withinthepreceding48h)UAandnon-STEMI815/14/2024BraunwaldclassificationofunstableanginaClinicalCircumstancesClassA:SecondaryUAPaclearlyidentifiedconditionextrinsictothecoronaryvascularbedthathasintensifiedmyocardialischemia,e.g.anemia,hypotension,tachy-arrhythmiaClassB:PrimaryunstableanginaClassC:Post-infarctionUAP(within2weeksofadocumentedMI)UAandnon-STEMI825/14/2024mechanism:

1.plaqueruptureanderosion,withnonocclusivethrombus2.dynamicobstruction:Vasoconstruction3.progressivemechnialobstruction(rapidlyadvancingorISRfollowingstenting)4.secondaryUAInflammationThrombogenesisUAandnon-STEMI835/14/2024

ECG:Non-STEMI:STdepressionlast>12hrCardiacbiomarkersofmyocardiumdamage:cTnT,cTnICK-MBUAPandnon-STEMICoronaryangiographyAngioscopyandIVUSOtherlaboratorytests845/14/2024Treatment1.Genearlmanagement:rest,oxygen,CCU2.DrugtherapyA.Anti-ischemicdrug:intravenously,orallynitrates

-blockerCalcium

antagnoist:firstchoiceforvariantanginaMorphinesulfateUAandnon-STEMI855/14/2024Treatment

2.Drugtherapy:B.antithrombotictherapya.Anti-plateletAspirin:early,300mgloadingdoseADP-receptorantagonist:clopidogrel300mg-600mgloadingdose,75mg/dGPIIb/IIIareceptorinhibitor:usedinptsplannedtoPCIb.Anticoagulationtherapy:HeparinLowmolecularweightheparin(LMWH)Directanti-thrombindrug:bivalirudin,hirudin

UAandnon-STEMI865/14/2024Treatment2.Drugtherapy:C.othermedicaltherapy

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論